Learning Objectives

After completing this activity, the participant should be able to:

  1. Describe findings from key clinical trials in the area of biologics for the treatment of psoriasis.
  2. Describe the pharmacologic action of new biologic agents.
  3. Discuss the proposed place in therapy of new biologic agents.
  4. Implement new treatment strategies in their clinical practice, to optimize patient care, using existing treatment modalities.
  5. Describe the long-term safety profile of the existing biologic agents and the advantages and disadvantages associated with their use.
  6. Describe future treatment strategies designed to improve patient quality of life and acceptability of biologic agents.

This activity is valid for one year and expires on March 24, 2010.